Blood natural killer cells during treatment in recurrent ovarian cancer.

CONCLUSIONS: A low blood NK cell count in recurrent metastatic ovarian cancer during chemotherapy is associated with unfavorable prognostic impact. Early increase in survival difference based on NK cell status suggests an association between NK cell count and treatment benefit.
PMID: 32692270 [PubMed - as supplied by publisher]

Source: Acta Oncologica - July 20, 2020 Category: Cancer & Oncology Authors: Henriksen JR, Nederby L, Donskov F, Waldstrøm M, Adimi P, Jakobsen A, Dahl Steffensen K Tags: Acta Oncol Source Type: research